BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 26659223)

  • 1. Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.
    Inno A; Bogina G; Turazza M; Bortesi L; Duranti S; Massocco A; Zamboni G; Carbognin G; Alongi F; Salgarello M; Gori S
    Oncologist; 2016 Jan; 21(1):28-32. PubMed ID: 26659223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine Tumors of the Breast.
    Rosen LE; Gattuso P
    Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare breast tumor: solid neuroendocrine carcinoma.
    Sanguinetti A; Santoprete S; Lucchini R; Triola R; Loreti F; Avenia N
    Ann Ital Chir; 2013; 84(1):81-5. PubMed ID: 22672972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid neuroendocrine carcinoma of the breast.
    Abbasi NZ; Zahur Z; Sheikh AS; Khan AA; Ali F; Memon KH; Moizuddin SS; Loya A; Barkat N
    J Coll Physicians Surg Pak; 2013 Nov; 23(10):820-2. PubMed ID: 24169396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
    Cloyd JM; Yang RL; Allison KH; Norton JA; Hernandez-Boussard T; Wapnir IL
    Breast Cancer Res Treat; 2014 Dec; 148(3):637-44. PubMed ID: 25399232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does hormonal therapy have a therapeutic role in metastatic primary small cell neuroendocrine breast carcinoma? Case report and literature review.
    Alkaied H; Harris K; Brenner A; Awasum M; Varma S
    Clin Breast Cancer; 2012 Jun; 12(3):226-30. PubMed ID: 22424945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates in primary neuroendocrine breast carcinoma - A case report and review of literature.
    Patel G; Bipte S
    J Cancer Res Ther; 2020; 16(6):1528-1531. PubMed ID: 33342825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
    Angarita FA; Rodríguez JL; Meek E; Sánchez JO; Tawil M; Torregrosa L
    World J Surg Oncol; 2013 Jun; 11():128. PubMed ID: 23734899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary neuroendocrine carcinoma of the breast.
    Lu CS; Huang SH; Ho CL; Chen JH; Chao TY
    J BUON; 2014; 19(2):419-29. PubMed ID: 24965401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroendocrine carcinoma of the breast: a rare entity].
    Sartori A; Scomersi S; Spivach A; Vigna S
    Chir Ital; 2009; 61(2):265-7. PubMed ID: 19537005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targets.
    Ang D; Ballard M; Beadling C; Warrick A; Schilling A; O'Gara R; Pukay M; Neff TL; West RB; Corless CL; Troxell ML
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):97-103. PubMed ID: 25679062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary large cell neuroendocrine carcinoma of the breast, a case report with an unusual clinical course.
    Janosky M; Bian J; Dhage S; Levine J; Silverman J; Jors K; Moy L; Cangiarella J; Muggia F; Adams S
    Breast J; 2015; 21(3):303-7. PubMed ID: 25823996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review].
    Feki J; Fourati N; Mnif H; Khabir A; Toumi N; Khanfir A; Boudawara T; Amouri H; Daoud J; Frikha M
    Cancer Radiother; 2015 Aug; 19(5):308-12. PubMed ID: 26215367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of neoadjuvant endocrine therapy in patients with poorly differentiated neuroendocrine carcinoma of the breast: A case report.
    Zhang Y; Liu C; Zheng C; Ren Q; Wang Q; Gao X; He Y; Wu J; Chen G; Li X; Ma Z
    Medicine (Baltimore); 2020 Oct; 99(43):e22652. PubMed ID: 33120755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine carcinoma of the breast--diagnostic and clinical implications.
    Watrowski R; Jäger C; Mattern D; Horst C
    Anticancer Res; 2012 Nov; 32(11):5079-82. PubMed ID: 23155283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
    López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
    Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary neuroendocrine carcinoma of the breast with leptomeninges metastasis: A case report and literature review.
    Yuan M; Chen D; Sun H; Wang X; Wan D
    J Int Med Res; 2022 Sep; 50(9):3000605221118505. PubMed ID: 36069002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
    Tang F; Wei B; Tian Z; Gilcrease MZ; Huo L; Albarracin CT; Resetkova E; Zhang H; Sahin A; Chen J; Bu H; Abraham S; Wu Y
    Histopathology; 2011 Jul; 59(1):106-15. PubMed ID: 21668471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping].
    Gao LX; Liu G; Li L; Lin HY; Jin H; Cheng J; Jin ML; Ding HY
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):604-9. PubMed ID: 22177244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.